# Takeyuki Hiramatsu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/takeyuki-hiramatsu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,591 |
| Field | Dialysis and Renal Disease Management |
| h-index | 15 |
| i10-index | 22 |
| Last Known Institution | Chubu University |
| OpenAlex ID | https://openalex.org/A5050456292 |
| ORCID iD | 0000-0001-7500-600X |
| Works | 70 |

## Researcher papers

- [Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial](https://scholariq.org/papers/febuxostat-therapy-for-patients-with-stage-3-ckd-and-asymptomatic-hyperuricemia/)
- [Plasma Adiponectin and Gastric Cancer](https://scholariq.org/papers/plasma-adiponectin-and-gastric-cancer/)
- [Predictive Factors for Negative Outcomes in Initial Non-operative Management of Suspected Appendicitis](https://scholariq.org/papers/predictive-factors-for-negative-outcomes-in-initial-non-operative-management-of/)
- [Peritonitis is still an important factor for withdrawal from peritoneal dialysis therapy in the Tokai area of Japan](https://scholariq.org/papers/peritonitis-is-still-an-important-factor-for-withdrawal-from-peritoneal-dialysis/)
- [Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients](https://scholariq.org/papers/long-term-effects-of-spironolactone-in-peritoneal-dialysis-patients/)
- [Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis](https://scholariq.org/papers/effect-of-treating-hyperphosphatemia-with-lanthanum-carbonate-vs-calcium/)
- [Quality of Life and Emotional Distress in Peritoneal Dialysis and Hemodialysis Patients](https://scholariq.org/papers/quality-of-life-and-emotional-distress-in-peritoneal-dialysis-and-hemodialysis/)
- [Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS)](https://scholariq.org/papers/incidence-of-remission-and-relapse-of-proteinuria-end-stage-kidney-disease/)
- [Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study](https://scholariq.org/papers/urate-lowering-therapy-for-ckd-patients-with-asymptomatic-hyperuricemia-without/)
- [Recent analysis of status and outcomes of peritoneal dialysis in the Tokai area of Japan: the second report of the Tokai peritoneal dialysis registry](https://scholariq.org/papers/recent-analysis-of-status-and-outcomes-of-peritoneal-dialysis-in-the-tokai-area/)
- [Liraglutide relieves cardiac dilated function than <scp>DPP</scp>‐4 inhibitors](https://scholariq.org/papers/liraglutide-relieves-cardiac-dilated-function-than-scp-dpp-scp-4-inhibitors/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

## Researcher university

- [Chubu University](https://scholariq.org/institutions/chubu-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.